6 completed, 1 terminated. 7 Phase 1.
By phase and status
Follow vilaprisan: new trials by email Literature Review of vilaprisan trials Research Report on vilaprisan
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment Vilaprisan (BAY1002670) - Uterine Fibroids, Endometriosis | Phase 1 | Completed | 26 | 2018-02-02 | 2019-12-03 |
Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned Vilaprisan, BAY1002670, Ulipristal - Leiomyoma | Phase 1 | Terminated | 10 | 2017-11-16 | 2021-01-06 |
Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC) Vilaprisan (BAY 1002670), Vilaprisan Placebo, Microgynon - Clinical Trial ,Phase I | Phase 1 | Completed | 71 | 2017-07-17 | 2019-02-28 |
Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) Vilaprisan (BAY1002670) - Leiomyoma | Phase 1 | Completed | 36 | 2017-03-28 | 2017-08-18 |
Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]Vilaprisan Vilaprisan (BAY1002670), [14C] Vilaprisan, Itraconazole(ITZ) - Clinical Trial, Phase I | Phase 1 | Completed | 14 | 2015-07-01 | 2016-03-02 |
Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan Vilaprisan (BAY1002670) - Clinical Trial, Phase I | Phase 1 | Completed | 70 | 2014-10-01 | 2016-03-16 |
Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 BAY1002670, Placebo - Leiomyoma | Phase 1 | Completed | 73 | 2011-11-01 | 2014-04-21 |
Conditions studied
Leiomyoma (4) · Endometriosis (1)
Sponsors
Bayer (7)
Countries
Germany (4) · United Kingdom (3) · Belgium (1) · United States (1)
Results publications
PMID 27288475, PMID 29330782
NIH funding
2014 (2), 2015 (1), 2016 (1), 2017 (1)